102 related articles for article (PubMed ID: 38858293)
1. Putting Wind in the Sails of Neoadjuvant Therapy for Locally Advanced Esophageal Adenocarcinoma: Perioperative Outcomes.
Meredith LT; Grenda TR
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38858293
[No Abstract] [Full Text] [Related]
2. Influence of Neoadjuvant Immunotherapy-Chemotherapy on Perioperative Outcomes in Locally Advanced Esophageal Adenocarcinoma.
Nevo Y; Tankel J; Zhao H; Ramirez J; Cools-Lartigue J; Muller C; Alcindor T; Ferri L
Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38530527
[TBL] [Abstract][Full Text] [Related]
3. Perioperative outcomes of neoadjuvant immunotherapy plus chemotherapy and neoadjuvant chemoradiotherapy in the treatment of locally advanced esophageal squamous cell carcinoma: a retrospective comparative cohort study.
Zhang H; Zhang Z; Yang L; Wu B; Chen Y; He H; Li C; Lin W; Lin J
J Thorac Dis; 2023 Mar; 15(3):1279-1288. PubMed ID: 37065590
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.
Hammoud ZT; Kesler KA; Ferguson MK; Battafarrano RJ; Bhogaraju A; Hanna N; Govindan R; Mauer AA; Yu M; Einhorn LH
Dis Esophagus; 2006; 19(2):69-72. PubMed ID: 16643172
[TBL] [Abstract][Full Text] [Related]
5. [The role of neoadjuvant therapy in multimodality treatment of locally advanced esophageal squamous cell carcinoma: perspective from the NEOCRTEC5010 trial].
Guo XF; Fang WT
Zhonghua Wai Ke Za Zhi; 2021 Aug; 59(8):646-650. PubMed ID: 34192855
[TBL] [Abstract][Full Text] [Related]
6. Perioperative or neoadjuvant chemotherapy for locally advanced gastric or gastroesophageal junction cancer: from independent evidence in the West, the East, and Japan to global collaboration.
Nakayama I; Ohashi M; Nunobe S
Chin Clin Oncol; 2024 Feb; 13(1):8. PubMed ID: 38453658
[TBL] [Abstract][Full Text] [Related]
7. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.
Iams WT; Villaflor VM
World J Surg; 2017 Jul; 41(7):1719-1725. PubMed ID: 28271259
[TBL] [Abstract][Full Text] [Related]
9. Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial.
Shi J; Li N; Tang Y; Jiang L; Yang L; Wang S; Song Y; Liu Y; Fang H; Lu N; Qi S; Chen B; Li Z; Liu S; Wang J; Wang W; Zhu S; Yang J; Li Y; Zhao D; Jin J
BMC Gastroenterol; 2022 Jul; 22(1):359. PubMed ID: 35902798
[TBL] [Abstract][Full Text] [Related]
10. RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
Lorenzen S; Biederstädt A; Ronellenfitsch U; Reißfelder C; Mönig S; Wenz F; Pauligk C; Walker M; Al-Batran SE; Haller B; Hofheinz RD
BMC Cancer; 2020 Sep; 20(1):886. PubMed ID: 32933498
[TBL] [Abstract][Full Text] [Related]
11. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
[TBL] [Abstract][Full Text] [Related]
12. [Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?].
Babic B; Fuchs HF; Bruns CJ
Chirurg; 2020 May; 91(5):379-383. PubMed ID: 32140748
[TBL] [Abstract][Full Text] [Related]
13. Postoperative complications after resection of borderline resectable and locally advanced pancreatic cancer: The impact of neoadjuvant chemotherapy with conventional radiation or stereotactic body radiation therapy.
Blair AB; Rosati LM; Rezaee N; Gemenetzis G; Zheng L; Hruban RH; Cameron JL; Weiss MJ; Wolfgang CL; Herman JM; He J
Surgery; 2018 May; 163(5):1090-1096. PubMed ID: 29395234
[TBL] [Abstract][Full Text] [Related]
14. Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma.
Vos EL; Carr RA; Hsu M; Nakauchi M; Nobel T; Russo A; Barbetta A; Tan KS; Tang L; Ilson D; Ku GY; Wu AJ; Janjigian YY; Yoon SS; Bains MS; Jones DR; Coit D; Molena D; Strong VE
Br J Surg; 2021 Nov; 108(11):1332-1340. PubMed ID: 34476473
[TBL] [Abstract][Full Text] [Related]
15. Low- vs. High-Dose Neoadjuvant Radiation in Trimodality Treatment of Locally Advanced Esophageal Cancer.
Ji KSY; Thomas SM; Roman SA; Czito B; Anderson KL; Frakes J; Adam MA; Sosa JA; Robinson TJ
J Gastrointest Surg; 2019 May; 23(5):885-894. PubMed ID: 30374818
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy and Radio-Chemotherapy of Locally Advanced Esophageal Cancer].
Wille K; Mann C; Berlth F; Fetzner UK; Othmann K; Mönig SP
Ther Umsch; 2022 Apr; 79(3-4):189-194. PubMed ID: 35440193
[TBL] [Abstract][Full Text] [Related]
17. Perioperative Outcomes of Minimally Invasive Esophagectomy After Neoadjuvant Immunotherapy for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma.
Cheng J; Guo M; Yang Y; Liu Y; Hu W; Shang Q; Li C; Xia L; Wang Y; Wang W; Tian D; Yuan Y; Hu Y; Chen L
Front Immunol; 2022; 13():848881. PubMed ID: 35371089
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer.
Xu X; Sun Z; Liu Q; Zhang Y; Shen L; Zhang C; Lin H; Hu B; Rong L; Chen H; Wang X; Zhao X; Bai YR; Ye Q; Ma X
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38458635
[TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001).
Shang X; Zhao G; Liang F; Zhang C; Zhang W; Liu L; Li R; Duan X; Ma Z; Yue J; Chen C; Meng B; Ren X; Jiang H
Ann Transl Med; 2022 Feb; 10(4):229. PubMed ID: 35280363
[TBL] [Abstract][Full Text] [Related]
20. Benefits of Supplemental Jejunostomy Tube Feeding During Neoadjuvant Therapy in Patients with Locally Advanced, Potentially Resectable Esophageal Cancer.
Dalton BGA; Friedant AJ; Su S; Schatz TAP; Ruth KJ; Scott WJ
J Laparoendosc Adv Surg Tech A; 2017 Dec; 27(12):1279-1283. PubMed ID: 28777676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
